Veracyte Return on Tangible Equity 2012-2025 | VCYT
Current and historical return on tangible equity values for Veracyte (VCYT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Veracyte Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.03B | $0.34B | 10.62% |
| 2024-12-31 | $0.02B | $0.33B | 8.36% |
| 2024-09-30 | $-0.01B | $0.31B | -3.35% |
| 2024-06-30 | $-0.05B | $0.27B | -21.47% |
| 2024-03-31 | $-0.07B | $0.25B | -28.42% |
| 2023-12-31 | $-0.07B | $0.25B | -32.17% |
| 2023-09-30 | $-0.05B | $0.24B | -22.96% |
| 2023-06-30 | $-0.03B | $0.22B | -13.99% |
| 2023-03-31 | $-0.03B | $0.21B | -15.50% |
| 2022-12-31 | $-0.04B | $0.20B | -19.12% |
| 2022-09-30 | $-0.04B | $0.20B | -23.28% |
| 2022-06-30 | $-0.05B | $0.19B | -26.34% |
| 2022-03-31 | $-0.05B | $0.19B | -21.38% |
| 2021-12-31 | $-0.08B | $0.19B | -28.87% |
| 2021-09-30 | $-0.07B | $0.18B | -23.82% |
| 2021-06-30 | $-0.06B | $0.34B | -17.97% |
| 2021-03-31 | $-0.07B | $0.34B | -21.33% |
| 2020-12-31 | $-0.04B | $0.36B | -13.42% |
| 2020-09-30 | $-0.03B | $0.36B | -15.89% |
| 2020-06-30 | $-0.03B | $0.16B | -17.32% |
| 2020-03-31 | $-0.02B | $0.16B | -11.47% |
| 2019-12-31 | $-0.01B | $0.17B | -7.12% |
| 2019-09-30 | $-0.01B | $0.22B | -5.62% |
| 2019-06-30 | $-0.01B | $0.21B | -10.58% |
| 2019-03-31 | $-0.02B | $0.07B | -27.78% |
| 2018-12-31 | $-0.02B | $0.07B | -54.66% |
| 2018-09-30 | $-0.03B | $0.07B | -92.31% |
| 2018-06-30 | $-0.03B | $0.01B | -151.90% |
| 2018-03-31 | $-0.03B | $0.02B | -124.00% |
| 2017-12-31 | $-0.03B | $0.02B | -98.36% |
| 2017-09-30 | $-0.03B | $0.03B | -72.73% |
| 2017-06-30 | $-0.03B | $0.03B | -76.92% |
| 2017-03-31 | $-0.03B | $0.04B | -100.87% |
| 2016-12-31 | $-0.03B | $0.04B | -119.23% |
| 2016-09-30 | $-0.04B | $0.02B | -147.37% |
| 2016-06-30 | $-0.04B | $0.02B | -125.62% |
| 2016-03-31 | $-0.04B | $0.03B | -95.36% |
| 2015-12-31 | $-0.03B | $0.04B | -95.77% |
| 2015-09-30 | $-0.03B | $0.04B | -103.82% |
| 2015-06-30 | $-0.03B | $0.05B | -109.09% |
| 2015-03-31 | $-0.03B | $0.02B | -105.08% |
| 2014-12-31 | $-0.03B | $0.02B | -80.00% |
| 2014-09-30 | $-0.03B | $0.03B | -61.54% |
| 2014-06-30 | $-0.03B | $0.05B | -67.97% |
| 2014-03-31 | $-0.03B | $0.05B | -86.21% |
| 2013-12-31 | $-0.03B | $0.06B | -151.52% |
| 2013-06-30 | $-0.02B | $0.01B | -900.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.971B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.740B | 80.48 |
| Thermo Fisher Scientific (TMO) | United States | $157.155B | 19.01 |
| Edwards Lifesciences (EW) | United States | $44.664B | 29.28 |
| Alcon (ALC) | Switzerland | $42.873B | 28.97 |
| IDEXX Laboratories (IDXX) | United States | $41.865B | 48.11 |
| DexCom (DXCM) | United States | $32.988B | 50.99 |
| IQVIA Holdings (IQV) | United States | $27.445B | 15.37 |
| Mettler-Toledo (MTD) | United States | $24.611B | 29.27 |
| STERIS (STE) | Ireland | $22.391B | 24.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.259B | 0.00 |
| Waters (WAT) | United States | $17.231B | 24.31 |
| Hologic (HOLX) | United States | $14.231B | 15.46 |
| Sysmex ADR (SSMXY) | Japan | $10.500B | 29.79 |
| Penumbra (PEN) | United States | $9.078B | 71.25 |
| Masimo (MASI) | United States | $8.645B | 31.89 |
| Globus Medical (GMED) | United States | $7.664B | 18.26 |
| Glaukos (GKOS) | United States | $5.628B | 0.00 |
| Teleflex (TFX) | United States | $5.008B | 8.27 |
| Integer Holdings (ITGR) | United States | $4.087B | 21.41 |
| TransMedics (TMDX) | United States | $3.833B | 83.32 |
| PROCEPT BioRobotics (PRCT) | United States | $3.156B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.344B | 13.96 |
| Nihon Kohden (NHNKY) | Japan | $2.188B | 25.10 |
| Elekta AB (EKTAY) | Sweden | $1.876B | 16.86 |
| Alphatec Holdings (ATEC) | United States | $1.554B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 125.96 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.058B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.049B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.940B | 5.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.36 |
| SiBone (SIBN) | United States | $0.729B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.585B | 12.67 |
| Beta Bionics (BBNX) | United States | $0.549B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.548B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 8.24 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.435B | 10.11 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.419B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.368B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.317B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| RxSight (RXST) | United States | $0.296B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Neuronetics (STIM) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.79 |
| CVRx (CVRX) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.144B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Accuray (ARAY) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.107B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.30 |
| Spectral AI (MDAI) | United States | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.22 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.56 |